EFFECT OF ANGIOTENSIN II AND BRADYKININ INHIBITION IN RAT REDUCED-SIZE LIVER TRANSPLANTATION
INSULIN-LIKE GROWTH FACTOR AND EPIDERMAL GROWTH FACTOR TREATMENT: NEW APPROACHES TO PROTECTING STEATOTIC LIVERS AGAINST ISCHEMIA-REPERFUSION INJURY.
PREVENTION OF I/R INJURY IN FATTY LIVERS BY ISCHEMIC PRECONDITIONING IS ASSOCIATED WITH INCREASED MITOCHONDRIAL TOLERANCE: THE KEY ROLE OF ATPSYNTHASE AND MITOCHONDRIAL PERMEABILITY TRANSITION.
THERAPEUTIC TARGETS IN LIVER TRANSPLANTATION: ANGIOTENSIN II IN NONSTEATOTIC GRAFTS AND ANGIOTENSIN-(1-7) IN STEATOTIC GRAFTS
